Total planned funding: $116,454,220
Allocations
Countries/Regions
Ukraine | $116,454,220 |
Organizational Types
Unknown | $32,668,021 |
Private Contractor | $29,078,578 |
NGO | $16,696,998 |
Own Agency | $12,371,343 |
Multi-lateral Agency | $11,288,586 |
University | $5,017,000 |
Other USG Agency | $4,711,694 |
Implementing Agency | $4,372,000 |
Host Country Government Agency | $250,000 |
Program Areas
Governance and Systems | $51,108,753 |
Treatment | $22,528,502 |
Prevention | $15,343,111 |
Testing | $9,465,825 |
Care | $9,046,508 |
Management and Operations | $8,961,521 |
Budget Codes
OHSS: Health Systems Strengthening | $26,505,077 |
HVSI: Strategic Information | $13,118,201 |
HLAB: Laboratory Infrastructure | $11,485,475 |
HTXD: Treatment: ARV Drugs | $11,431,114 |
HTXS: Treatment: Adult Treatment | $11,097,388 |
HVCT: Testing: HIV Testing and Counseling | $9,465,825 |
HVMS: Management and Operations | $8,961,521 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $7,353,306 |
HVTB: Care: TB/HIV | $5,496,766 |
HVOP: Sexual Prevention: Other Sexual Prevention | $5,025,930 |
HMBL: Biomedical Prevention: Blood Safety | $2,251,624 |
HKID: Care: Orphans and Vulnerable Children | $1,860,190 |
HBHC: Care: Adult Care and Support | $1,689,552 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $293,357 |
HMIN: Biomedical Prevention: Injection Safety | $250,000 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $168,894 |
Top Partner Programs
Not Available:
$32,668,021
Countries/Regions
Chemonics International:
$16,839,470
Countries/Regions
USG Aggregated Agencies:
$11,556,343
Countries/Regions
Deloitte Consulting Limited:
$10,239,108
Countries/Regions